SuperworthVertex Pharmaceuticals shares outstanding VRTX
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 255.2M
- On a year earlier
- −1.4%
- fewer shares
Vertex Pharmaceuticals had 255.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 256.1M | −2% |
| FY2024 | 260.5M | −0% |
| FY2023 | 260.9M | +0% |
| FY2022 | 260.3M | +1% |
| FY2021 | 257M | −2% |
| FY2020 | 263.1M | +0% |
| FY2019 | 262.1M | +1% |
| FY2018 | 259.8M | +1% |
| FY2017 | 256.8M | +4% |
| FY2016 | 247.8M | +2% |
| FY2015 | 243M | +2% |
| FY2014 | 238.6M | +1% |
| FY2013 | 235.7M | +10% |
| FY2012 | 214.6M | −1% |
| FY2011 | 217.6M | +8% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 255.2M | −1% | |
| Q1 FY26 | 256.3M | −1% | |
| Q4 FY25 | 256.1M | −2% | |
| Q3 FY25 | 257.6M | −1% | |
| Q2 FY25 | 258.9M | +0% | |
| Q1 FY25 | 259.5M | −1% | |
| Q4 FY24 | 260.5M | −0% | |
| Q3 FY24 | 261M | +0% | |
| Q2 FY24 | 258.1M | −1% | |
| Q1 FY24 | 261.1M | +0% | |
| Q4 FY23 | 260.9M | +0% | |
| Q3 FY23 | 260.6M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Vertex Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.